How many studies have been conducted on Apolipoprotein E3?

BiohacksAI has indexed 245 PubMed studies on Apolipoprotein E3, including 2 randomized controlled trials (RCTs). 28% of studies involve human subjects.

What are the main research areas for Apolipoprotein E3?

The primary research domains for Apolipoprotein E3 are 🔥 Metabolic, 🧠 Neuroprotection, ❤️ Cardiovascular. This is based on analysis of 245 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Apolipoprotein E3

A 34-kDa glycosylated protein. A major and most common isoform of apolipoprotein E. Therefore, it is also known as apolipoprotein E (ApoE). In human, Apo E3 is a 299-amino acid protein with a cysteine at the 112 and an arginine at the 158 position. It is involved with the transport of TRIGLYCERIDES; PHOSPHOLIPIDS; CHOLESTEROL; and CHOLESTERYL ESTERS in and out of the cells.

245+ PubMed studies analyzed · 2 RCTs · Evidence Score: 45.5

Research Domains

Apolipoprotein E3 has been studied across 18 research domains including 🔥 Metabolic, 🧠 Neuroprotection, ❤️ Cardiovascular, 🔬 Oncology, 🫁 Liver & Detox. The primary research focus is 🔥 Metabolic with 27% of studies addressing this area.

Loading evidence profile...

This evidence profile for Apolipoprotein E3 is generated deterministically from 245 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.